medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2006, Number 1

<< Back Next >>

An Med Asoc Med Hosp ABC 2006; 51 (1)

Subcutaneous venous reservoir. Report of 105 cases

Torres PJL, Gerson R, Villalobos A, Serrano A, González JM, Garmilla J, Ramírez C

Language: Spanish
References: 45
Page: 11-17
PDF size: 120.24 Kb.


ABSTRACT

Objective: The purpose of this study is to analyse the procedure of installation and the complications associated with subcutaneous vein reservoir (SVR) installed for seven and half years. Design: Multicentric, retrosprospective, observational, nonrandomized, noncomparative study. Patients and methods: From January of 1997 to June of 2004, a total of 105 subcutaneous vein reservoir were installed on one hundred and two patients by just one surgical team. Results: Of 102 patients, 76 were female and 26 male, with an average age of 48. On 92 patients the indication for the installation of the Subcutaneous Vein Reservoir was for chemotherapy, and the other ten were for parenteral nutrition. The specific oncologic diagnosis was: breast cancer 57.1%, gynecological cancer 13.3% and hematological cancer 8.5%. There was no intraoperative morbidity or mortality. There was no surgical morbidity, three cases had late catheter infection, 6, 7 and 4 months after, and 2 with catheter malfunction because of proximal bending. Conclusion: Subcutaneous Vein Reservoir is an excellent vascular access, with a minimal morbidity rate and is safe and comfortable for the patient.


REFERENCES

  1. Harvey WH, Pick TE, Reed K, Solenberger RI. A prospective evaluation of the Port-A-Cath implantable venous access system in chronically ill adults and children. Surg Gynecol Obstet 1989; 169: 495-500.

  2. Kalso F. A short history of central venous catheterization. Acta Anaesth Scand 1985; suppl 82: 7-10

  3. Gerson R, Rojas G, Guadiana E. Catéteres venosos centrales. Historia. An Med Asoc Med Hosp ABC 1994; 39: 22-26.

  4. Hermosura B, Vanagas L, Dickey MW: Measurement of pressure during intravenous therapy. JAMA 1966; 321-322.

  5. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parentheral alimentation. Surg Gynecol Obstet 1973; 136: 602-606.

  6. Hickman R, Buckner D, Clift R, Sanders J, Stewart P, Thomas D. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148: 871-873.

  7. Cervantes G et al. Implanted vascular access system for chemotherapy. Proc ASCO 1991; 1204: 340.

  8. Rojas G, Gerson R, Cervantes J, Arcos L, Villalobos A. Reservorio subcutáneo venosos como acceso vascular en el paciente oncológico. Rev Inst Nal Cancerol (Mex) 1997; 43: 136-141.

  9. Johnson J. Complications of vascular access devices. Emergency Med Clin North Am 1994; 12: 691-705.

  10. Soeters R, Uys P, Dehaeck K, Bloch B. The Port-A-Cath a totally skin covered venous access system for long term cytotoxic treatment. SANJ 1989; 75: 146-147.

  11. Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982; 92: 706-712.

  12. Del Olmo E M, Soto BJM, García JM, Lozano BA, Martínez MJL. Reservorios venosos subcutáneos. Técnica y resultados. Cir Esp 1992; 52: 264-268.

  13. Freytes CO. Indications and complications of intravenous devices for chemotherapy. Curr Opin Oncol 2000; 12: 303-307.

  14. Rosenblum DI, Geisinger MA, Newman JS et al. Use of subcutaneous venous access ports to treat refractory ascites. J Vasc Interv Radiol 2001; 12: 1343-1346.

  15. Gerson R, Rojas G, Serrano A, Flores F, Villalobos A. Complicaciones asociadas a catéter Port-A-Cath. Rev Med Hosp Gen Mex 1998; 61: 14-18.

  16. Cózar IA, Del Olmo EM, Moreno MJM, Jiménez AF, Quesada PMC: Experiencia clínica con reservorios venosos subcutáneos en pacientes oncológicos. Rev Oncol 2004; 6 (1): 30-36.

  17. Rojas G, Gerson R, Cervantes J, Flores C, Villalobos A. Acceso vascular en el paciente oncológico. Experiencia de 200 casos. Cir Cir 1999; 67: 200-204.

  18. Brincker H, Saeter G. Fifty-five patient years´ experience with a totally implanted system for intravenous chemotherapy. Cancer 1986; 57: 1124-1129.

  19. Greene F, Moore W, Strickland G et al. Comparison of a totally implantable access device for chemotherapy (Port-ACath) and long-term percutaneous catheterization (Broviac). South Med J 1988; 81: 580-583.

  20. McDowell HP, Hart CA, Martin J. Implantable subcutaneous venous catheters. Arch Dis Child 1986; 61: 1037-1038.

  21. Alliende F, Antillon F, Sierrasesumaga L, Villa I. Experiencia con el uso de un sistema de acceso venoso subcutáneo en 57 pacientes pediátricos. Bol Med Hosp Infant Mex 1990; 47: 576-579.

  22. Erhard J, Lange R, Kremens B, Krauze J, Eigler FW. Experiences with a modified implantation technique of Port-A-Cath systems as continuous venous access in infants and children. Med Klin 1991; 86: 512-514.

  23. Hall P, Cedermark B, Swedenborg J. Implantable catheter system for long-term intravenous chemotherapy. J Surg Oncol 1989; 41: 39-41.

  24. Pettengell R, Davies AJ, Harvey VJ. Experience with an implantable venous access system for chemotherapy. NZ Med J 1991; 104: 284-285.

  25. Strum S, McDermed J, Korn A, Joseph C. Improved methods for venous access: The Port-A-Cath a totally implanted catheter system. J Clin Oncol 1986; 4: 596-603.

  26. Koonings P, Given F. Long term experience with a totally implanted catheter system in gynecologic oncologic patients. J Am Coll Surg 1994; 178: 164-166.

  27. Gerson R, Rojas G, Lázaro M et al. Complicaciones mayores asociadas al uso de catéteres Hickman-Broviac en 103 pacientes oncológicos: Trombosis e infección. Cir Cir 1994; 62: 127-131.

  28. Schmid L, Walser K, Kessler W, Senn HJ. Use of a fully implantable drug delivery system in the treatment of acute leukemias and disseminated lymphomas. Oncology 1990; 47 (6): 449-455.

  29. Robinson M, Halverson P. Port A Cath: A study of complication rates. SDJ Med 1991; 44: 187-190.

  30. Biffi R de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsh A, Nole F, Andreoni B. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimur follow-up of 180 days. Ann Oncol 1998; 7: 767-773.

  31. Bow EJ, Kilpatrick MG, Clinch JJ. Totally implantable venous access port system for patients receiving chemotherapy for solid malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J Clin Oncol 1999; 17: 1267-1272.

  32. Di Carlo I, Cordio S, La Greca G et al. Totally implantable venous access devices implanted surgically: A retrospective study on early and late complications. Arch Surg 2001; 136: 1050-1053.

  33. Aitken DR, Minton JP. The pinch off sign: A warning of impending problems with permanent subclavian catheters. Am J Surg 1984; 148: 633-636.

  34. Lafreniere R. Indwelling subclavian catheters and a visit with the pinched off sign. J Surg Oncol 1991; 47: 261-264.

  35. Gerson R, Rojas G, Elizalde J, Ruiz Speare O, Romaguera J. Fractura de catéter central. Complicación por evitar. An Med Asoc Med Hosp ABC 1993; 38 (2): 71-75.

  36. Ballarini C, Intra M, Pisan Ceretti A, Cordovana A,Pagani M, Farina G, Perrone S, Tomirotti M, Scanni A, Pina GP. Complications of subcutaneous infusion port in the general oncology population. Oncology 1999; 56: 97-102.

  37. Cózar IA, Del Olmo EM, Navarrete SI, Cosano AA, Sánchez RP, Moreno MJM. Fractura espontánea y migración intravascular del catéter en los reservorios venosos subcutáneos. Cir Esp 1999; 65: 163-165.

  38. Rojas G, Gerson R, Lázaro M. Acceso vascular con catéteres Broviac-Hickman. Rev Inst Nal Cancerol (Mex) 1992; 38: 1701-1705.

  39. Rojas G, Hernández A, Ponte R, Gerson R, Arcos L, Guzmán de Alba E. Manipulación endovascular percutánea de catéteres venosos centrales colocados en posición incorrecta. Cir Gen 1996; 18: 276-279.

  40. Whitman ED. Complications associated with the use of central venous access devices. Curr Probl Surg 1996; 33: 309-378.

  41. Schwarz RE, Groeger JS, Coit DG. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 1997; 79: 1635-1640

  42. Kuriakose P, Colon Otero G, Paz-Fumagalli R. Risk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters: A 5 year single-institution retrospective study. J Vasc Interv Radiol 2002; 13: 179-184.

  43. Minassian VA, Sood AK, Lowe P, Sorosky JI, Al-Jurf AS, Buller RE. Longterm central venous access in gynaecologic cancer patients. J Am Coll Surg 2000; 191: 403-409.

  44. Rojas G, Gerson R, Cervantes J, Arcos L, Villalobos A, Ponte R: Trombosis venosa profunda y/o tromboembolismo pulmonar en el paciente oncológico. Rev Inst Nal Cancerol (Mex) 1996; 42: 92-96.

  45. LaQuaglia P, Lucas A, Thaler H et al. A prospective analysis of vascular access device related infections in children. J Pediatr Surg 1992; 27: 840-842.




2020     |     www.medigraphic.com